M.D, 1.Lower Silesian Center 2. Private Research Institute of Nature, Poland
Dr. Przemysław Zdziarski is an accomplished M.D., Ph.D., and habilitated doctor in the field of medicine, specializing in clinical immunology and infectious diseases. He graduated from the Military Medical Academy in 1996 and went on to receive a Ph.D. in medicine in 2002 for his groundbreaking research on drug hypersensitivity. Over the years, Dr. Zdziarski has made significant contributions to interdisciplinary translational medicine, collaborating with leading institutions such as the Hirszfeld Institute of Immunology and Experimental Therapy, and the Military Institute of Engineering Technology. He currently practices as a senior specialist at the Lower Silesian Oncology, Pulmonology & Hematology Center. His research areas include immunodeficiencies, immunotherapy, inflammatory adverse drug reactions, microbiome research, and oncology. He has authored over 40 publications and holds multiple patents for mobile water filtration technology. Dr. Zdziarski has earned multiple awards and distinctions for his innovative work in immunology and clinical research.
Profile
Strengths for the Award:
Extensive and Diverse Research Background: Dr. Zdziarski’s career has spanned over two decades of significant contributions to medicine, with a focus on immunology, infectious diseases, and translational research. His work is characterized by a multidisciplinary approach, merging immunology, microbiome research, and clinical immunology to address key healthcare challenges. His research interests cover a broad spectrum, including immunodeficiencies, opportunistic infections, adverse drug reactions, vaccines, oncogenesis, and immunotherapy.
- Highly Productive Researcher: Dr. Zdziarski is the first author of over 40 peer-reviewed publications, many of which have made substantial contributions to the fields of immunology, infectious diseases, and pharmacovigilance. His work has been widely cited, and his papers have been recognized in leading journals. The research on immunoglobulin-induced anaphylaxis, T-cell responses, and microbiome impacts on immunotherapy, particularly in cancer and COVID-19, underscores his capacity to address emerging and critical clinical issues.
- Awards and Recognition: Dr. Zdziarski has received numerous awards, both for his scientific and organizational contributions. Notably, his distinctions at major international congresses (e.g., the European and World Congress of Immunology) and recognition for his work on immunomodulation in rare diseases, passive blood anaphylaxis, and the role of microbiome in disease progression highlight the high impact of his work. His scientific achievements have earned him awards at conferences in Stockholm, Berlin, and Montreal, which speak to the quality and innovation of his research.
- Collaborative and Interdisciplinary Approach: Dr. Zdziarski has a proven record of successful collaboration with top scientific institutions, such as the Hirszfeld Institute of Immunology, the Military Institute of Engineer Technology (WITI), and the Lower Silesian Oncology, Pulmonology & Hematology Center. His ability to work with interdisciplinary teams—combining expertise in microbiology, immunology, and clinical medicine—enables him to advance research with direct applications to clinical practice.
- Innovative Contributions: Beyond traditional research, Dr. Zdziarski has contributed to technological innovation, with two patents and a utility model related to mobile water filters for military and humanitarian use, demonstrating his ability to translate scientific discoveries into real-world applications.
- Mentorship and Leadership: As a senior specialist and consultant, Dr. Zdziarski has played a key role in shaping clinical practice and research at several institutions. His leadership in the Hospital Infections Control Team and his role as a consultant for the Polish Armed Forces and the Hirszfeld Institute of Immunology further demonstrate his influence on public health and academic development.
Areas for Improvement
- Broader Recognition in Clinical Immunology: While Dr. Zdziarski is well-recognized in academic circles and has contributed significantly to research in immunology and infectious diseases, there is room for further outreach to clinical practitioners, especially in the integration of his research on the microbiome and immunotherapy into daily clinical practice. Greater dissemination of his findings to the broader medical community could improve clinical outcomes.
- Greater Focus on Translational Impact: While Dr. Zdziarski’s work has been highly influential in academic settings, it could be beneficial to place more emphasis on the long-term translational impact of his research. Continued work to bridge the gap between laboratory findings and real-world clinical applications will solidify his position as a leader in clinical translational medicine.
- Diversification of Funding Sources: While Dr. Zdziarski has been involved in several prestigious collaborations, pursuing additional funding from diverse sources, such as private sector partnerships or international research foundations, could expand the scope of his work and its clinical applications.
Education
Dr. Przemysław Zdziarski completed his medical education at the Military Medical Academy in Łódź, Poland, earning his M.D. in 1996. He further pursued research, obtaining a Ph.D. in 2002 from the same institution for his work on drug hypersensitivity. In 2003, he became a certified Infectious Disease Specialist after completing his specialization. Dr. Zdziarski continued his clinical training in clinical immunology, receiving a specialist title in 2006 after training at the Lower Silesian Center for Cellular Transplantation and the Hirszfeld Institute of Immunology and Experimental Therapy in Wrocław. In 2023, he earned his habilitation degree (post-doctoral degree) in medicine for his research on the human microbiome. Throughout his education, Dr. Zdziarski has received numerous distinctions for his academic achievements and contributions to scientific advancement. His continuous commitment to improving clinical and immunological research underscores his expertise in the medical field.
Research Focus
Dr. Przemysław Zdziarski’s research focuses on immunodeficiencies, opportunistic infections, and inflammatory adverse drug reactions. His interdisciplinary approach spans translational medicine, taking innovative scientific findings from the laboratory to real-world clinical applications. Notably, Dr. Zdziarski has contributed significantly to the field of immunotherapy, especially in the context of rare diseases and drug-induced complications. He has also expanded his research to include the human microbiome, exploring its role in various diseases and its interaction with immunological therapies. His work on drug hypersensitivity and drug-induced immune reactions has resulted in significant advances in pharmacovigilance and immunological diagnostics. Dr. Zdziarski is also an expert in oncology, with particular interest in immunooncology, and has contributed to understanding the immunological basis of tumor biology. His collaborative research across various institutions underscores his commitment to multidisciplinary approaches in advancing precision medicine.
Selected Publications
- Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency 🩸💉
- Overuse of high stability antibiotics and its consequences in public and environmental health 🌍💊
- Elizabethkingia miricola as an opportunistic oral pathogen associated with superinfectious complications in humoral immunodeficiency 🦠🦷
- A case of stiff person syndrome: immunomodulatory effect of benzodiazepines: successful rituximab and tizanidine therapy 💊🧠
- Detection of Polish clinical Aspergillus fumigatus isolates resistant to triazoles 🌿🔬
- Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation and the European Society for Immunodeficiency 🧬💉
- A case report of lymphoid interstitial pneumonia in common variable immunodeficiency 🫁💥
- CMV-specific immune response—New patients, new insight: Central role of specific IgG during infancy and long-lasting immune deficiency after allogenic stem cell transplantation 🧫🧬
- Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings 🦠🧓
- Microbiome Analysis and Pharmacovigilance After Inhaled Glucocorticoid: Oral Dysbiosis With the Isolation of Three Rothia Species and Subsequent Sjögren’s Syndrome Development 🔬🦠
Conclusion
Dr. Przemysław Zdziarski is a highly deserving candidate for the Best Researcher Award. His outstanding scientific achievements, impactful contributions to clinical immunology and microbiome research, and his ability to innovate in healthcare technologies make him an exemplary candidate. His work has already had a significant impact on the fields of immunodeficiencies, immunotherapy, and infectious diseases. With further focus on translational research and clinical outreach, Dr. Zdziarski’s future contributions have the potential to transform medical practice, especially in the domains of precision medicine and immune-related therapies. His leadership, productivity, and commitment to scientific advancement make him an invaluable asset to the global research community.